Back to Journals » Journal of Hepatocellular Carcinoma » Volume 6 » default

Journal of Hepatocellular Carcinoma


Archive: Volume 6, 2019

Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida

Jones PD, Scheinberg AR, Muenyi V, Gonzalez-Diaz J, Martin PM, Kobetz E

Journal of Hepatocellular Carcinoma 2019, 6:167-181

Published Date: 15 November 2019

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine

Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T, Liu M, Han J, Li Z, Chen S

Journal of Hepatocellular Carcinoma 2019, 6:151-166

Published Date: 18 October 2019

Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma

Zakka K, Jiang R, Alese OB, Shaib WL, Wu C, Wedd JP, Sellers MT, Behera M, El-Rayes BF, Akce M

Journal of Hepatocellular Carcinoma 2019, 6:119-129

Published Date: 22 July 2019

Intermediate stage hepatocellular carcinoma: a summary review

Elshaarawy O, Gomaa A, Omar H, Rewisha E, Waked I

Journal of Hepatocellular Carcinoma 2019, 6:105-117

Published Date: 11 July 2019

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK

Journal of Hepatocellular Carcinoma 2019, 6:93-103

Published Date: 17 June 2019

Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma

Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML

Journal of Hepatocellular Carcinoma 2019, 6:85-91

Published Date: 6 June 2019

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB

Journal of Hepatocellular Carcinoma 2019, 6:49-69

Published Date: 5 February 2019

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach

Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK

Journal of Hepatocellular Carcinoma 2019, 6:41-48

Published Date: 31 January 2019

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date

Personeni N, Pressiani T, Rimassa L

Journal of Hepatocellular Carcinoma 2019, 6:31-39

Published Date: 31 January 2019

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M

Journal of Hepatocellular Carcinoma 2019, 6:1-10

Published Date: 21 December 2018